ERBB2 and cancer: In general, Lauren intestinal subtype progressed from normal epithelia to early well-differentiated cancer through the sequence of Helicobacter pylori infection, cyclin E over-expression, and mutations of APC, TP53, and KRAS. Then, the early well-differentiated cancer suffered from HER2 amplification, leading to advanced cancer and metastasis [26].